Etiopathogenesis and pathophysiology of cholestasis
-
Published:2022-10-31
Issue:
Volume:
Page:97-117
-
ISSN:
-
Container-title:Exploration of Digestive Diseases
-
language:en
-
Short-container-title:Explor Dig Dis
Author:
Asensio Maitane1ORCID, Ortiz-Rivero Sara1ORCID, Morente-Carrasco Ana2ORCID, Marin Jose J. G.1ORCID
Affiliation:
1. Experimental Hepatology and Drug Targeting (HEVEPHARM), University of Salamanca, Institute for Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain 2. Experimental Hepatology and Drug Targeting (HEVEPHARM), University of Salamanca, Institute for Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain
Abstract
Normal hepatobiliary function depends on an adequate bile flow from the liver through the biliary tree to the gallbladder, where bile is stored and concentrated, and from the gallbladder to the duodenum when it is required for the digestive process. Interruption of this secretory function results in partial or complete cholestasis, which is accompanied by important repercussions due to the lack of bile acids in the intestine and their regurgitation from hepatocytes to blood together with potentially toxic compounds that are normally eliminated in bile. The presence of active and selective transporter proteins located at both poles of the plasma membrane of hepatocytes, cholangiocytes, and epithelial cells of the ileal mucosa, together with the ability of hepatocytes to synthesize bile acids from cholesterol, enables the so-called bile acid enterohepatic circulation, which is essential in liver and gastrointestinal tract physiology. The presence in the ducts of the biliary tree of agents reducing their luminal diameter by external compression or space-occupying obstacles, either in the duct wall or its lumen, can result in total or partial obstructive cholestasis. The clinical impact and management of cholestasis are different depending on the intrahepatic or extrahepatic location of the obstacle. Thus, surgical interventions can often be helpful in removing extrahepatic obstructions and restoring normal bile flow to the duodenum. In contrast, hepatocyte or cholangiocyte damage, either global, restricted to subcellular compartments, or more specifically affecting the elements of the canalicular secretory machinery, may result in hepatocellular cholestasis or cholangiopathies. In these cases, bile flow interruption is usually partial and, except for extremely severe cases when liver transplantation is required, these patients often treated with pharmacological agents, such as ursodeoxycholic acid (UDCA) and rifampicin. The present review gathers updated information on the etiopathogenesis and pathophysiological aspects of different types of cholestasis.
Funder
European Regional Development Fund Junta de Castilla y León Fundació la Marató de TV3 Consejería de Educación, Junta de Castilla y León
Publisher
Open Exploration Publishing
Subject
Ecology, Evolution, Behavior and Systematics,Experimental and Cognitive Psychology,Ecology, Evolution, Behavior and Systematics,General Computer Science,Social Psychology,Ecology, Evolution, Behavior and Systematics,Nature and Landscape Conservation,Ecology, Evolution, Behavior and Systematics,Library and Information Sciences,Communication,Earth-Surface Processes,Geography, Planning and Development,Multidisciplinary,General Chemistry,Biochemistry,General Medicine,Biophysics,General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference130 articles.
1. Jüngst C, Berg T, Cheng J, Green RM, Jia J, Mason AL, et al. Intrahepatic cholestasis in common chronic liver diseases. Eur J Clin Invest. 2013;43:1069–83. 2. Brauer RW. Mechanisms of bile secretion. J Am Med Assoc. 1959;169:1462–6. 3. Sperber I. Secretion of organic anions in the formation of urine and bile. Pharmacol Rev. 1959;11:109–34. 4. Marin JJG. How we have learned about the complexity of physiology, pathobiology and pharmacology of bile acids and biliary secretion. World J Gastroenterol. 2008;14:5617–9. 5. Galman C, Angelin B, Rudling M. Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19. J Intern Med. 2011;270:580–8.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|